Afamelanotide

Products Afamelanotide is administered as an implant (Scenesse, Clinuvel). It has had orphan drug status in many countries since 2008. It has not yet been registered with Swissmedic and is not approved as a drug. In the United States, the drug was approved in 2019. Structure and properties Afamelanotide is an analog of α-melanocyte-stimulating hormone … Afamelanotide

Bufexamac

Products Bufexamac was on the market in many countries as a cream and as an ointment (Parfenac). Because the active ingredient frequently causes allergic contact dermatitis, distribution of the drugs was discontinued. Structure and properties Bufexamac or 2-(4-butoxyphenyl)–hydroxyacetamide (C12H17NO3, Mr = 223.3 g/mol) is a white to almost white crystalline powder that is practically insoluble … Bufexamac

Clenbuterol

Products Clenbuterol is not commercially available as a human drug in many countries, but exclusively as a veterinary drug for the treatment of respiratory diseases (e.g., Ventipulmin ad us vet). It is available only on medical prescription. In other countries, clenbuterol is on the market in tablet and drop form (Spiropent). Structure and properties Clenbuterol … Clenbuterol